Skip to Content

'
Shiao Y. Woo, M.D.

Present Title & Affiliation

Primary Appointment

Professor and Section Chief of CNS/Pediatrics, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1972 University of Malaysia, Kuala Lumpur, Malaysia, M.B., B.S., Faculty of Medicine

Postgraduate Training

1/1985-1/1988 Residency in Radiation Therapy, Stanford University Medical Center, Stanford, CA
1/1978-1/1980 Fellowship in Pediatric and Adolescent Oncology-Hematology, Vincent T. Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC
1/1976-1/1978 Residency in Pediatrics, Georgetown University Hospital, Washington, DC
1/1976-5/1976 Residency in Pediatrics, Southern General Hospital, Glasgow, Scotland, United Kingdom
1/1973-1/1975 Residency in Internal Medicine, Johor Baru General Hospital, Johor Baru, Malaysia
1/1972-1/1973 Clinical Internship, Ipoh General Hospital, Ipoh, Malaysia

Board Certifications

1/1988 American Board of Radiation Oncology-(Oral Board)
1/1987 American Board of Radiation Oncology-(Written Board)
1/1980 American Board of Pediatrics
1/1980 Subspecialty Board in Pediatric-Hematology-Oncology
1/1979 FLEX
1/1976 Specialty Board in Internal Medicine, U.K.
1/1976 Diploma of Child Health, London
1/1975 M.R.C.P. (U.K.)

Experience/Service

Academic Appointments

Professor (non-tenure), Pediatrics, Department of Pediatrics Patient Care, Baylor College of Medicine, Houston, TX, 1/2002-1/2004
Professor (tenure), Department of Radiology, Baylor College of Medicine, Houston, TX, 1/1996-1/2004
Adjunct Associate Professor, Department of Radiology, UT Heath Science Center, Houston, TX, 1/1994-1/2004
Associate Professor, Department of Radiology, Baylor College of Medicine, Houston, TX, 1/1992-1/1996
Assistant Professor of Radiotherapy and Pediatrics, Department of Pediatrics Patient Care, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 1/1988-1/1991
Assistant Professor of Pediatrics, Department of Pediatrics Patient Care, Tufts University School of Medicine, Boston, MA, 1/1981-1/1985
Assistant Professor of Pediatrics, Department of Pediatrics Patient Care, Georgetown University School of Medicine, Washington, DC, 1/1980-1/1981

Administrative Appointments/Responsibilities

Associate Chairman of Research Department of Radiology, Department of Radiology, Baylor College of Medicine, Houston, TX, 1/2001-1/2004
Residency Program Director, Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, 1/1991-1/2004
Residency Program Director, Department of Radiation Oncology, Division of Radiation Oncology, UT M. D. Anderson Cancer Center, Houston, TX, 1/1989-1/1991

Other Appointments/Responsibilities

Executive Committee, Pediatric Radiation Oncology Society, N/A, 1/2006-present
Board of Directors, Medical Dosimetrist Certification Board, Mt. Laurel, NJ, 2006-2010
Councilor, Texas Radiological Society to American College of Radiology, N/A, 1/2004
Board of Trustees, Houston Neurological Society, N/A, 1/2003
Scientific Committee, American Society for Therapeutic Radiology and Oncology, N/A, 1/2000
Examiner - Oral Exams, American Board of Radiology (Radiation Oncology), N/A, 1/2000
Examiner - Oral Exams, American Board of Radiology (Radiation Oncology), N/A, 1/1999
Examiner - Oral Exams, American Board of Radiology (Radiation Oncology), N/A, 1/1998
Executive Committee, Texas Radiological Society, N/A, 1/1998
Standing Program Committee, Gilbert Fletcher Society, N/A, 1/1998
Radiation Research Committee, American Society for Therapeutic Radiology and Oncology, N/A, 1/1997
Examiner - Oral Exams, American Board of Radiology (Radiation Oncology), N/A, 1/1996
Co-Principal Investigator, Texas Children’s Hospital, Houston, TX, 1/1991-present
Adjuct Asistant Professor, Baylor College of Medicine, Houston, TX, 1/1991-1/1992
Tumor Registry Committee, New England Medical Center, Boston, MA, 1/1982-1/1985

Institutional Committee Activities

Member, St. Luke’s Episcopal Hospital Cancer Committee, 1/1998-1/2004
Member, St. Luke's Episcopal Hospital Non TCON Scientific Review Committee, 1/1998-12/1998
Member, The Methodist Hospital Cancer Committee, 1/1997-1/2000
Member, The Institutional Review Board for Human Subject Research, 1/1997-1/2000
Member, Baylor College of Medicine Residency Training Committee, 1/1991-1/2004
Member, Investigational Drug Committee, The Methodist Hospital, 1/1989-1/1991
Member, Products Standards/Evaluation Committee,The Methodist Hospital, 1/1988-1/1991

Honors and Awards

2008 2008 Patient Golden Apple Award, MDAnderson Cancer Center
2002-2009 Best Doctors of America

Selected Publications

Peer-Reviewed Original Research Articles
1. Chang EL, Akyurek S, Avalos T, Rebueno N, Spicer C, Garcia J, Famigliettie R, Allen PK, Chao C, Mahajan A, Woo SY, Maor MH. Evaluation of Peritumoral Edema in the Delineation of Radiotherapy Clinical Target Volumes for Gliobalstoma. INT J Radiat Oncol Biol Phys. In Press. e-Pub 2/2007.
2. JaniN, Krull KR, Brouwers P, Chintagumpala MM, Woo SY. Neuropsychological outcome following intensity-modulated radiation therapy for pediatric medulloblastoma. Pediatr Blood Cancer. e-Pub 4/2008.
3. Anderson Pete, Aguilera Dolly, Pearson Margaret, Woo Shiao. Outpatient Chemotherapy Plus Radiotherapy in Sarcomas: Improving Cancer Control with Radiosensitizing Agents. Cancer Control Journal of the Moffitt Cancer Center Vol. 15:38-46, 1/2008.
4. Schroeder TM, Chintagumpala M, Okcu MF, Chiu JK, Teh BS, Woo SY, and Paulino AC. Intensity-Modulated Radiation Therapy in Childhood Ependymoma. Int J Radiat Onol Biol Phys, 2008.
5. Thomas Merchant, Larry E. Kun, Mathew J. Krasin, Dana Wallace, Murali M. Chintagumpala, Shiao Woo, David Ashley, Maree Sexton, Stewart J. Kellie, Verity Ahern, Amar Gajjar. Multi-Institution Prospective Trial of Reduced- Dose Craniospinal Irradiation (23.4 GY) Followed by Conformal Posterior Fossa (36 GY) and Primary Site Irradiation (55.8 GY) and Dose-Intensive Chemotherapy for Average- Risk Medullablastoma. Int. J. Radiation Oncology Biol. Phys. 70:782-787, 2008.
6. Sue S. Yom, Erik K. Frija, Anita Mahajan, Eric Chang, Kelli Klein, Almon Shiu, Jared Ohrt, and Shiao Woo. Field in Field Technique with Intrafractionally Modulated Junction Shifts for Crainospinal Irradiation IJROBP Vol. 69:1193-1198, 6/2007.
7. Hermanto U, Frija EK, Lii MF, Chang EL, Mahajan A, Woo SY. Intensity Modulated Radiotherapy (IMRT) and Conventional Radiotherapy for High-Grade Gliomas: Does IMRT Increase the Integral Dose to Normal Brain? Int J Radiat Oncol Biol Phys 67(4):1135-1144, 3/2007.
8. Chang EL, Wefel JS, Maor MH, Ater JL, Mahajan A, Lang FF, Woo SY, Mathews L, Allen P, Shiu AS, Meyers C. A Pilot Study of neurocognitive Function in patients with 1 to 3 New Brain Metastases Initially Treated with Stereotactic Radiosurgery Alone. Neurosurgery 60 (2):227-284, 2007.
9. Akyurek S, Chang EL, Mahajan A Hassenbusch SJ 3rd, Allen PK, Mathews LA, Shiu AS, Maor MH, Woo SY. Stereotactic Radiosurgical Treatment of Cerebral Metastases Arising from Breast Cancer. AM J Clin Oncol, 2007.
10. Nguyen QN, Chang EL, Allen PK, Maor MH, Ater JL, Mahajan A, Wolff JE, Weinberg JS, Woo SY. Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure. Cancer 107:2228-36, 11/2006. PMID: 17019739.
11. Akyurek S, Chang EL, Yu TK, Little D, Allen PK, McCutcheon I, Mahajan A, Maor MH, Woo SY. Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center. J Neurooncol 80:177-83, 11/2006. PMID: 16648988.
12. Pelloski CE, Lin E, Zhang L, Yung WK, Colman H, Liu JL, Woo SY, Heimberger AB, Suki D, Prados M, Chang S, Barker FG, 3rd, Fuller GN, Aldape KD. Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res 12:3935-41, 7/2006. PMID: 16818690.
13. Chintagumpala MM, Friedman HS, Stewart CF, Kepner J, McLendon RE, Modrich PL, McCluggage C, Burger P, Holmes E, Thompson S, Rutka J, Michalski J, Woo S, Blaney SM, Kun LE, Horowitz ME, Horowitz ME. A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group. J Neurooncol 77(2):193-8, 4/2006. PMID: 16314955.
14. Wang L, Wei Q, Wang LE, Aldape KD, Cao Y, Okcu MF, Hess KR, El-Zein R, Gilbert MR, Woo SY, Prabhu SS, Fuller GN, Bondy ML. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol 24(10):1627-32, 4/2006. PMID: 16575014.
15. Amar Gajjar, Murali Chintagumpala, David Ashley, Steward Kellie, Larry E. Kun, Thomas Merchant, Shiao Woo, Greg Wheeler, Valerie Ahern, Mathew J. Krasin, Maryam Fouladi, Albero Broniscer, Robert Krance, Gregory A Hale, Clinton F. Stewart, Robert A Sanford, Christine Fuller, Ching Lau, James M Boyett, Dana Wallace, Richard J Gilbertson. Risk- adapted craniospinal radiotherapy followed by high- dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma- 96): long-term results from a prospective, multicentre trial. Lancet Oncol 10:813-820, 2006.

Last updated: 9/16/2009